title: Manifesto for a European anxiety disorders research network.
abstract: Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.
authors.affiliation: Clinical Neuroscience Division, University of Southampton School of Medicine, Southampton, UK. dsb1@soton.ac.uk
authors.forename: David S
authors.initials: DS
authors.lastname: Baldwin
authors.forename: Christer
authors.initials: C
authors.lastname: Allgulander
authors.forename: Alfredo Carlo
authors.initials: AC
authors.lastname: Altamura
authors.forename: Jules
authors.initials: J
authors.lastname: Angst
authors.forename: Borwin
authors.initials: B
authors.lastname: Bandelow
authors.forename: Johan
authors.initials: J
authors.lastname: den Boer
authors.forename: Patrice
authors.initials: P
authors.lastname: Boyer
authors.forename: Simon
authors.initials: S
authors.lastname: Davies
authors.forename: Bernardo
authors.initials: B
authors.lastname: Dell'osso
authors.forename: Elias
authors.initials: E
authors.lastname: Eriksson
authors.forename: Naomi
authors.initials: N
authors.lastname: Fineberg
authors.forename: Mats
authors.initials: M
authors.lastname: Fredrikson
authors.forename: Andres
authors.initials: A
authors.lastname: Herran
authors.forename: Eduard
authors.initials: E
authors.lastname: Maron
authors.forename: Andres
authors.initials: A
authors.lastname: Metspalu
authors.forename: David
authors.initials: D
authors.lastname: Nutt
authors.forename: Nic
authors.initials: N
authors.lastname: van der Wee
authors.forename: Jose Luis
authors.initials: JL
authors.lastname: Vázquez-Barquero
authors.forename: Joseph
authors.initials: J
authors.lastname: Zohar
mesh_terms: D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000150:complications / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D015897:Comorbidity; D032921:Consensus; D017281:Cost of Illness; D003469:Culture; D005060:Europe / Q000453:epidemiology; D006801:Humans; D015337:Multicenter Studies as Topic; D011634:Public Health; D012106:Research; D012109:Research Support as Topic; D017211:Treatment Failure
chemical_list: D014151:Anti-Anxiety Agents